Effects of Lusutrombopag on Post-invasive Procedural Bleeding in Thrombocytopenic Patients with Chronic Liver Disease.

Although a decrease in bleeding events as adverse events has been reported [ 5 , 10 ] and there is an observed trend toward a reduction in bleeding events with lusutrombopag than with placebo/PT, the evidence is insufficient to conclude that the preventive effect of lusutrombopag against bleeding is superior to that of PT.

also in 504 other papers